News
Our latest moves
All
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno raises $100 million to bring artificial intelligence to gene therapy
Press
Stat News
May 6, 2021
Dyno raises $100 million to bring artificial intelligence to gene therapy
Press
Stat News
May 6, 2021
Giant steps: Dyno closes $100M series A round for advanced capsid engineering
Press
BioWorld
May 6, 2021
Giant steps: Dyno closes $100M series A round for advanced capsid engineering
Press
BioWorld
May 6, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach to Create New AAV Capsids for Gene Therapies
Announcements
December 2, 2019
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach to Create New AAV Capsids for Gene Therapies
Announcements
December 2, 2019
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Low-N OpenFold fine-tuning improves peptide design without additional structures
Publications
NeurIPS MLSB
October 4, 2024
Low-N OpenFold fine-tuning improves peptide design without additional structures
Publications
NeurIPS MLSB
October 4, 2024
Contrastive losses as generalized models of global epistasis
Publications
38th Conference on Neural Information Processing Systems
May 1, 2024
Contrastive losses as generalized models of global epistasis
Publications
38th Conference on Neural Information Processing Systems
May 1, 2024
Bionemo Framework: A Modular, High-Performance Library For AI Model Development In Drug Discovery
Publications
Arxiv
May 1, 2024
Bionemo Framework: A Modular, High-Performance Library For AI Model Development In Drug Discovery
Publications
Arxiv
May 1, 2024
Beyond the training set: an intuitive method for detecting distribution shift in model-based optimization
Publications
Arxiv
November 9, 2023
Beyond the training set: an intuitive method for detecting distribution shift in model-based optimization
Publications
Arxiv
November 9, 2023
Generative design for gene therapy: An in vivo validated method
Publications
NeurIPS GenBio
October 27, 2023
Generative design for gene therapy: An in vivo validated method
Publications
NeurIPS GenBio
October 27, 2023
Forecasting labels under distribution-shift for machine-guided sequence design
Publications
PMLR
August 3, 2023
Forecasting labels under distribution-shift for machine-guided sequence design
Publications
PMLR
August 3, 2023
Dyno to scale the heights of AAV vector engineering
Press
BioWorld
December 6, 2019
Dyno to scale the heights of AAV vector engineering
Press
BioWorld
December 6, 2019